Song, Hanbing http://orcid.org/0000-0002-2164-8813
Weinstein, Hannah N. W. http://orcid.org/0000-0001-8409-4654
Allegakoen, Paul
Wadsworth, Marc H. II
Xie, Jamie
Yang, Heiko
Castro, Ethan A.
Lu, Kevin L.
Stohr, Bradley A.
Feng, Felix Y. http://orcid.org/0000-0002-0963-7687
Carroll, Peter R.
Wang, Bruce http://orcid.org/0000-0003-3486-5494
Cooperberg, Matthew R.
Shalek, Alex K. http://orcid.org/0000-0001-5670-8778
Huang, Franklin W. http://orcid.org/0000-0001-5447-0436
Article History
Received: 28 October 2020
Accepted: 29 October 2021
First Online: 10 January 2022
Change Date: 17 March 2022
Change Type: Update
Change Details: The Peer Review file was missing from this article and has now been uploaded.
Competing interests
: A.K.S. reports compensation for consulting and/or SAB membership from Merck, Honeycomb Biotechnologies, Cellarity, Hovione, Repertoire Immune Medicines, Ochre Bio, Third Rock Ventures, Relation Therapeutics, and Dahlia Biosciences. F.Y.F. reports compensation for consulting and/or SAB membership from Astellas, Bayer, Blue Earth Diagnostics, Celgene, Genentech, Janssen Oncology, Myovant, Roivant, Sanofi, PFS Genomics, and SerImmune. The remaining authors declare no competing interests.